Related Experiment Video
Updated: Oct 5, 2026

Ultrasonic Assessment of Myocardial Microstructure
Published on: January 14, 2014
Cyclic variation of the myocardial integrated backscatter signal in hypertensive cardiopathy: a preliminary study
V Di Bello1, R Pedrinelli, A Bertini
1Cardiac and Thoracic Department, University of Pisa, Italy. dibellov@po.ifc.pi.cnr.it
Insights
Hypertensive heart disease alters myocardial function, as indicated by reduced cyclic variation in integrated backscatter (CVI(IBS)) in the left ventricle. Athlete
Area of Science:
- Cardiology
- Biomedical Ultrasound
- Medical Imaging
Background:
- Left ventricular hypertrophy (LVH) in hypertensive cardiopathy shows myocardial texture abnormalities.
- These abnormalities are not observed in the athlete's heart.
- Ultrasound integrated backscatter analysis can characterize myocardial tissue.
Purpose of the Study:
- To compare ultrasonic backscatter myocardial indexes in hypertensive cardiopathy and athlete's heart.
- To analyze peak end-diastolic signal intensity and cardiac-cyclic variation in two models of LVH.
Main Methods:
- Analyzed three groups of 10 men each: athletes (cyclists), hypertensive patients, and controls.
- Used 2D-color Doppler echocardiography for conventional analysis.
- Utilized an 'acoustic densitometry' module for ultrasonic myocardial integrated backscatter signal (IBS) analysis, including cyclic variation index (CVIibs).
Main Results:
- Left ventricular mass was comparable between athletes and hypertensive patients, and significantly higher than controls.
- No significant difference in end-diastolic IBS among groups.
- Cyclic variation index (CVIibs) was significantly lower in hypertensive patients compared to athletes and controls at both septum and posterior wall levels.
Conclusions:
- Hypertensive cardiopathy is associated with significant alterations in myocardial cyclic variation of integrated backscatter (CVIibs).
- These findings suggest impaired intramural myocardial function in hypertensive heart disease.
Background:
Ultrasound tissue characterization studies realized through integrated backscatter analysis with end-diastolic sampling in hypertensive cardiopathy have demonstrated that abnormalities in the left ventricular myocardial ultrasonic texture are present in extreme forms of left ventricular hypertrophy (LVH). Such abnormalities are not evident in the athlete's heart. The aim of the present study was to analyze the ultrasonic backscatter myocardial indexes both as peak end-diastolic signal intensity and as cardiac-cyclic variation in two models of LVH: hypertensive cardiopathy and athlete's heart.
Methods:
Three groups of 10 subjects each, all men of mean age (31.6+/-3.5 years), and of comparable weight and height, were analyzed. Group A comprised 10 cyclists of good professional level, while hypertensive patients were grouped in Group H. Both groups presented a comparable left ventricular mass (LVM). Group C included 10 healthy subjects acting as controls. The men with hypertension were selected on the basis of the results of ambulatory monitoring of the blood pressure according to ISH-World Health Organization guidelines (International Society of Hypertension). A 2D-color Doppler echocardiography with a digital echograph Sonos 5500 (Agilent Technologies, Andover, Massachusetts, USA), was carried out on all the subjects in the study for conventional analysis of the LVM and function. The ultrasonic myocardial integrated backscatter signal (IBS) was analyzed with an 'acoustic densitometry' module implemented on a AT echograph. The signal was also sampled with a region of interest (ROI) placed at interventricular septum and at posterior left ventricular wall level. The systo-diastolic variation of the backscatter was also considered, as cyclic variation index (CVIibs).
Results:
According to the inclusion criteria, the LVM was comparable in groups A and H, but it was significantly higher than group C (left ventricular mass (body surface) (LVMbs)=154.5+/-18.7 (A), 146.8+/-25.5 (H), 101.4+/-12.4 (C), p < 0.001). The end-diastolic IBS did not show significant statistical differences among the three groups. The CVI(IBS) both at septum (30.5+/-5.3 (A), 13.2+/-13.1 (H), 27.2+/-7.3(C), p < 0.002) and posterior wall level (43.7+/-9.1 (A), 16.5+/-12.1 (H), 40.7+/-9.1 (C), p < 0.001) though, was significantly lower in the hypertensive patients than in both the athletes and the control group, where the results were comparable.
Conclusion:
A significant alteration of the myocardial CVIibs (both for septum and posterior wall) was found in the hypertensive model. This was probably the expression of an alteration in the intramural myocardial function.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
11:50High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
Published on: July 9, 2010
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies